Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythrocyte electrophoretic mobility test for multiple sclerosis

D Caputo, A Ghezzi, A Zibetti

    Bollettino Dell'Istituto Sieroterapico Milanese
    |March 31, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

    Physical review letters·2026
    Same author

    First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

    Physical review letters·2026
    Same author

    Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

    Physical review letters·2026
    Same author

    Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

    Physical review letters·2026
    Same author

    Observation of tWZ Production at the CMS Experiment.

    Physical review letters·2026
    Same author

    First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

    Physical review letters·2026
    Same journal

    Epidemiological evaluation by rRNA-DNA hybridization of strains of Salmonella enterica subsp. enterica serovar Abortusovis isolated in southern Italy in the years 1981-1989.

    Bollettino dell'Istituto sieroterapico milanese·1991
    Same journal

    Chlamydia trachomatis infection in "sine causa" recurrent abortion.

    Bollettino dell'Istituto sieroterapico milanese·1991
    Same journal

    [Levels of interleukin-4 (IL-4) in lymphocyte cultures of subjects with HIV-1 infection].

    Bollettino dell'Istituto sieroterapico milanese·1991
    Same journal

    HTLV-I and HIV-I antibody frequency in thalassemics and drug addicts in southeast Sicily.

    Bollettino dell'Istituto sieroterapico milanese·1991
    Same journal

    Fluconazole resistance of Candida krusei.

    Bollettino dell'Istituto sieroterapico milanese·1991
    Same journal

    [Urinary tract infection in an ambulatory population: epidemiological analysis of the etiology and antibiotic resistance of isolated gram-negative strains].

    Bollettino dell'Istituto sieroterapico milanese·1991
    See all related articles

    A new blood test for Multiple Sclerosis (M.S.), the E-UFA test, shows promise. It correctly identified M.S. in most patients, suggesting it is a valid diagnostic tool.

    Area of Science:

    • Neurology
    • Biomarker Discovery
    • Diagnostic Testing

    Background:

    • Multiple Sclerosis (M.S.) is a chronic autoimmune disease affecting the central nervous system.
    • Current diagnostic methods for M.S. can be invasive or time-consuming.
    • There is a need for accurate and accessible diagnostic tools for M.S.

    Purpose of the Study:

    • To evaluate the diagnostic accuracy of the E-UFA blood test for Multiple Sclerosis (M.S.).
    • To determine the sensitivity and specificity of the E-UFA test in distinguishing M.S. patients from healthy controls and those with other neurological conditions (OND).

    Main Methods:

    • Statistical analysis was employed to review the performance of the E-UFA test.
    • The test was administered to a cohort including M.S. patients, control subjects, and individuals with other neurological conditions (OND).

    Related Experiment Videos

    Main Results:

    • The E-UFA test yielded positive results in 18 out of 22 M.S. patients.
    • The test was negative in all control subjects and patients diagnosed with other neurological conditions (OND).

    Conclusions:

    • The E-UFA blood test demonstrates significant validity for diagnosing Multiple Sclerosis (M.S.).
    • These findings support the potential of the E-UFA test as a reliable biomarker for M.S. detection.